Capricorn Fund Managers’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.42M Buy
40,100
+20,100
+101% +$594K 0.11% 131
2026
Q1
$554K Sell
20,000
-425,500
-96% -$10.9M 0.09% 99
2025
Q4
$9.67M Buy
445,500
+247,000
+124% +$4.87M 2.33% 11
2025
Q3
$3M Buy
+198,500
New +$2.46M 1.01% 33

Other funds holding ROIV

Capricorn Fund Managers's ROIV Position: Q2 2026 in Review

Capricorn Fund Managers increased its Roivant Sciences (ROIV) stake by 101% in Q2 2026, buying an estimated $594K and bringing the position to 40,100 shares worth $1.42M. The position accounts for 0.11% of the portfolio, ranked #131.

Capricorn Fund Managers first reported a position in ROIV in Q3 2025 and has held it in 4 quarters since. The position peaked at $9.67M in Q4 2025. 165 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Capricorn Fund Managers held 40,100 shares of Roivant Sciences worth $1.42M as of Q2 2026.
  • Capricorn Fund Managers bought 20,100 Roivant Sciences shares in Q2 2026, an estimated $594K.
  • Roivant Sciences made up 0.11% of Capricorn Fund Managers's portfolio in Q2 2026, its #131 holding.
  • Capricorn Fund Managers first reported a position in Roivant Sciences in Q3 2025 and has held it in 4 quarters since.
  • Capricorn Fund Managers's Roivant Sciences position peaked at $9.67M in Q4 2025.
  • 165 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Capricorn Fund Managers's 13F filing for Q2 2026, filed 24 Jul 2026.